Sabra Health Care REIT, Inc.
SBRAUS売上高
$357M
百万USD
営業利益
-
百万USD
純利益
$156M
百万USD
ROE
5.5%
最新FY
EPS
$0.64
USD / 株
配当
$1.20
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $36M | - | $0.16 |
| FY2021 | Q2 | $39M | $-133M | $-0.61 |
| FY2021 | Q3 | $40M | $10M | $0.05 |
| FY2021 | FY | $156M | $-113M | $-0.52 |
| FY2022 | Q1 | $42M | $41M | $0.18 |
| FY2022 | Q2 | $44M | $17M | $0.07 |
| FY2022 | Q3 | $48M | $-50M | $-0.22 |
| FY2022 | FY | $187M | $-78M | $-0.34 |
| FY2023 | Q1 | $57M | $-9M | $-0.04 |
| FY2023 | Q2 | $58M | $21M | $0.09 |
| FY2023 | Q3 | $60M | $-15M | $-0.07 |
| FY2023 | FY | $236M | $14M | $0.06 |
| FY2024 | Q1 | $66M | $26M | $0.11 |
| FY2024 | Q2 | $68M | $24M | $0.10 |
| FY2024 | Q3 | $74M | $30M | $0.13 |
| FY2024 | FY | $285M | $127M | $0.54 |
| FY2025 | Q1 | $77M | $40M | $0.17 |
| FY2025 | Q2 | $79M | $66M | $0.27 |
| FY2025 | Q3 | $92M | $23M | $0.09 |
| FY2025 | FY | $357M | $156M | $0.64 |
| FY2026 | Q1 | $117M | $41M | $0.16 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | $128M | $156M | $156M | $187M | $236M | $285M | $357M |
| 営業利益 | - | - | - | - | - | - | - | - | - | - |
| 純利益 | $70M | $158M | $279M | $69M | $138M | $-113M | $-78M | $14M | $127M | $156M |
| 総資産 | $2.3B | $7.0B | $6.7B | $6.1B | $6.0B | $6.0B | $5.7B | $5.4B | $5.3B | $5.5B |
| 純資産 | $1.0B | $3.4B | $3.3B | $3.5B | $3.4B | $3.4B | - | - | - | $2.8B |
| 自己資本 | $1.0B | $3.4B | $3.3B | $3.5B | - | $3.4B | $3.1B | $2.8B | $2.7B | $2.8B |
| 営業CF | $177M | $133M | $359M | $372M | $355M | $356M | $316M | $301M | $311M | $349M |
| EPS | $0.92 | $1.40 | $1.51 | $0.37 | $0.67 | $-0.52 | $-0.34 | $0.06 | $0.54 | $0.64 |
| BPS | $15.56 | $19.26 | $18.23 | $16.99 | - | $14.64 | $13.22 | $12.11 | $11.52 | $11.19 |
| ROE | 6.9% | 4.6% | 8.6% | 2.0% | - | -3.4% | -2.5% | 0.5% | 4.6% | 5.5% |